Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20

April 8, 2010

Recordati signs marketing agreement with Esteve for pitavastatin

April 8, 2010

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

April 8, 2010

Asahi Kasei grants Altheos exclusive rights to AK-138 series compounds for glaucoma

April 7, 2010

Warner Chilcott assumes full commercial responsibility for Actonel in U.S.

April 7, 2010

Teijin and Astellas to market TMX-67 for hyperuricemia in gout patients in China and Hong Kong

April 7, 2010

Takeda and Janssen to comarket Alzheimer's disease therapeutic galantamine in Japan

April 7, 2010

AMAG and Takeda enter into agreement to develop and market Feraheme

April 6, 2010

GSK and Isis to develop RNA-targeted therapeutics for rare and infectious diseases

April 6, 2010

NeurOp and Bristol-Myers Squibb enter drug discovery collaboration

April 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...